Hepatocellular adenoma: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
|||
Line 16: | Line 16: | ||
==[[Hepatocellular adenoma causes|Causes]]== | ==[[Hepatocellular adenoma causes|Causes]]== | ||
==[[Hepatocellular adenoma epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Hepatocellular adenoma epidemiology and demographics|Epidemiology and Demographics]]== |
Revision as of 16:41, 21 October 2015
For patient information, click here
Hepatocellular adenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatocellular adenoma On the Web |
American Roentgen Ray Society Images of Hepatocellular adenoma |
Risk calculators and risk factors for Hepatocellular adenoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., PhD., Nawal Muazam M.D.[2]
Synonyms and keywords: Hepadenoma; Hepatic adenoma; Liver cell adenoma; Liver adenoma; Liver cell adenomatosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hepatocellular adenoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Contraindicated medications
Hepatic adenoma is considered an absolute contraindication to the use of the following medications:
- Drospirenone and Ethinyl estradiol
- Norethindrone acetate and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol